TARGETWATCH
BIBiogaia
Biogaia
Seneste kurs
117,30 SEK
22.7.2026
Seneste
140,00 SEK
+19.35%
Opside
3 mdr.
146,67 SEK
+25.04%
Opside
BIOG-B
3 mdr.+25,04%3 kursmål
6 mdr.+24,47%5 kursmål
1 år+24,47%5 kursmål
Max 6 kursmål
Danske BankSB1 MarketsDNB Carnegie
SundhedDrug Manufacturers—Specialty & Generic

Om selskabet

Biogaia AB is a Swedish biotechnology company that develops and sells probiotic products. Biogaia has been developed from research findings on the lactic acid bacterium Limosilactobacillus reuteri and the substance reuterin, which was carried out by Walter Dobrogosz and Sven Lindgren in the 1980s.
Wikipedia

Seneste kursmål

Kursmål
140,00 SEK
Opside
+19,35%
Seneste kurs117,30 SEK

Tre måneders konsensus

Konsensus
146,67 SEK
Opside
+25,04%
Seneste kurs117,30 SEK

Insiderhandel for Biogaia

Ingen insiderhandler for den valgte periode.

Flere kursmål for Biogaia

Analytiker
Dato
Jul 21
Kursmål
140,00 SEK

Analytiker
Dato
Jul 20
Kursmål
135,00 SEK

Analytiker
Dato
May 8
Kursmål
165,00 SEK

Analytiker
Dato
Apr 2
Kursmål
130,00 SEK

Analytiker
Dato
Apr 2
Kursmål
160,00 SEK

Dato
Feb -23
Kursmål
130,00 SEK